FamilyTreeHealth
Competitive Intelligence
A deep-dive into the 5 closest competitors to LineageMD — on pricing, features, user pain points, and the white space no one is filling.
Feature Comparison Matrix
Every feature was verified against live App Store listings, competitor websites, and web search results. ✅ = confirmed available, ❌ = confirmed absent, ⚠️ = partial or limited implementation.
| Feature | LineageMD (proposed) | FamGenix | Family Vitals | MyHeritage | Ancestry | SelfDecode |
|---|---|---|---|---|---|---|
| Family health history entry | ✅ Visual tree UI | ✅ Form-based | ✅ Member profiles | ⚠️ Genealogy only | ⚠️ Genealogy only | ❌ Individual only |
| No DNA required | ✅ Core premise | ✅ No DNA needed | ✅ Records-based | ⚠️ Optional DNA kit | ⚠️ Optional DNA kit | ❌ DNA required |
| On-device AI risk analysis | ✅ Foundation Models | ⚠️ Rule-based only | ⚠️ AI chat (cloud) | ❌ | ❌ | ✅ Cloud AI (DNA) |
| Doctor-ready PDF export | ✅ Clinical pedigree format | ⚠️ Pedigree share (clinical) | ❌ | ❌ | ❌ | ❌ |
| HealthKit integration | ✅ BP, glucose, BMI | ❌ | ✅ Vitals tracking | ❌ | ❌ | ❌ |
| Fully on-device / private | ✅ Zero server | ⚠️ HIPAA cloud | ⚠️ iCloud-based | ❌ Cloud required | ❌ Cloud required | ❌ Cloud required |
| Family tree visual display | ✅ SwiftUI canvas | ✅ Pedigree chart | ❌ List-based only | ✅ Genealogy tree | ✅ Genealogy tree | ❌ |
| Multi-member family sharing | ✅ CloudKit / iCloud | ✅ Invite relatives | ✅ Up to 10 members | ✅ Shared tree | ✅ Shared tree | ❌ Individual only |
| One-time purchase model | ✅ $7.99 unlock | ✅ Free (B2B) | ❌ Subscription | ❌ Subscription | ❌ Subscription | ❌ Subscription |
| Hereditary risk pattern identification | ✅ AI-powered clusters | ⚠️ Hereditary cancer only | ❌ | ❌ | ❌ | ✅ DNA-based |
| Offline functionality | ✅ Fully offline | ⚠️ Requires account | ⚠️ Partial | ❌ | ❌ | ❌ |
| Consumer-focused UX (not clinical) | ✅ Designed for families | ❌ Clinical/B2B UI | ⚠️ Some polish | ✅ Consumer-grade | ✅ Consumer-grade | ⚠️ Complex UI |
No competitor delivers all four of: (1) no DNA required, (2) on-device AI risk analysis, (3) doctor-ready PDF export, and (4) one-time purchase pricing. LineageMD is the only proposed solution that checks all four. FamGenix is closest on purpose but fails on UX, monetization, and on-device AI. Ancestry and MyHeritage are genealogy tools, not health tools.
Pricing Breakdown
All pricing data was verified via web search against live App Store listings and official competitor websites as of April 2026. Unverified entries are marked explicitly.
| App | Model | Free Tier Limits | Paid Price | What's Behind Paywall | DNA Required? |
|---|---|---|---|---|---|
| LineageMD (proposed) | One-Time | Up to 3 members free | $7.99 one-time | Unlimited members, AI risk patterns, doctor PDF export | No |
| FamGenix | Free | Full app free (consumer) | Free (B2B licensing) | Nothing — consumer app is entirely free; revenue is B2B hospital licensing | No |
| Family Vitals | Subscription | Unverified — likely limited members | Unverified — estimated $4.99–$9.99/mo | AI health assistant, full record storage, up to 10 members | No |
| MyHeritage | Freemium + DNA Kit | 250-person tree, no historical records | $89–$199/yr (verified, myheritage.com 2026) DNA kit: $79–$199 separately |
Smart Matches, historical record database (39.3B records), advanced DNA features, unlimited tree size | Optional |
| Ancestry | Subscription + DNA Kit | Very limited — hints only, no record access | $19.99–$44.99/mo (verified, ancestry.com 2026) Pro Tools: +$10/mo add-on |
Full US and international historical records, DNA match tools, family tree insights, Pro Tools (error check, maps, reports) | Optional |
| SelfDecode | Subscription + DNA Upload | Upload DNA free — no insights without subscription | $9.99/mo or $119/yr (verified, selfdecode.com 2026) PGx Report: +$99 add-on |
AI health recommendations from DNA, 1,500+ trait reports, pharmacogenomics, ancestry reports | Yes — DNA required |
Three of the five direct competitors use recurring subscriptions. Ancestry charges up to $45/month and then adds a $10/month Pro Tools surcharge on top. MyHeritage auto-renews at up to $299/year — with 27%+ of Trustpilot reviewers citing billing surprises as their #1 complaint. SelfDecode requires both a subscription AND a DNA kit. In this environment, LineageMD's $7.99 one-time price is a competitive moat, not just a choice. It signals privacy and fairness in a category defined by billing abuse.
Competitor Deep Dives
Each competitor card is built from verified data: App Store listings, official pricing pages, Trustpilot, PissedConsumer, Sensor Tower estimates, and web search results. Where data could not be confirmed, it is marked as "Unverified."
Consumer app is completely free. Revenue model is B2B white-label hospital and clinical licensing. The consumer app serves as a patient funnel into the clinical system — no consumer IAPs, no subscription. Raised $1.26M total (Crunchbase). Not profitable at this funding level.
- Family health history entry for hereditary disease risk (hereditary cancer focus — US/Canada)
- Invite relatives to contribute their branch of the family tree
- Connect with participating clinicians and share pedigree chart — HIPAA/GDPR compliant
$0 consumer / B2B: Unverified
- Missing common conditions (allergies, migraines, fibromyalgia) — no "other" input field
- Cannot add great-grandparents, aunts/uncles — tree depth limited
- Requires phone number for sign-up — barrier to entry; restricted to age 18+
- Clinical form-like UI — intimidating for consumers, not designed for general audiences
Subscription model — exact pricing not publicly listed on App Store page (Unverified from web search). Based on feature set and comparable apps, estimated $4.99–$9.99/month. Stores up to 10 family members' medical records. AI health assistant chat included in paid tier. 2024 launch — very limited reviews visible.
- Medical records, vaccines, medications, and vitals storage for up to 10 members (including pets)
- AI health assistant chat that uses medical history when responding
- Doctor appointment reminders, hospital record sync, document scanning
Unverified — likely <$5K/mo (very new, limited reviews)
- Broad medical records manager — not focused on hereditary risk patterns or family tree visualization
- No on-device AI — cloud-dependent chat assistant (privacy concern)
- No doctor-ready PDF export in clinical pedigree format
- Subscription feels costly for what is essentially a document storage app
Free tier: 250 people, no historical records. Premium: $89/yr (first year, regularly $129) — 2,500 person tree, Smart Matches. Data: $129/yr (regularly $189) — full 39.3 billion historical record database. Complete: $199/yr (regularly $299) — unlimited tree + all records. DNA kit sold separately at $79–$199. All prices verified via myheritage.com April 2026.
- Smart Matches to other family trees globally; Instant Discoveries for one-click branch additions
- Access to 39.3 billion historical records (census, birth, death, military)
- Advanced photo enhancement: blur correction, colorization of black-and-white photos
~$300K/mo (Sensor Tower estimate)
- Aggressive subscription upsell — 27%+ of Trustpilot reviewers give 1-star over billing surprises and unauthorized renewals
- Can no longer upload DNA from other labs — seen as anticompetitive and greedy
- Customer service unresponsive — email back-and-forth for weeks, no resolution (PissedConsumer: 1.9/5, 706 reviews)
- Purely genealogy — zero health pattern identification, no medical risk context
Three subscription tiers (verified, ancestry.com 2026): U.S. Discovery: $19.99/mo or $9.99/mo annual. World Explorer: $29.99/mo or $19.99/mo annual. All Access: $44.99/mo or $29.99/mo annual. Pro Tools: +$10/mo add-on (error checking, maps, reports — formerly free features). DNA kit additional. Company revenue: $1.31B ARR (2023 filing, Irish Times). 3.6M+ paying subscribers.
- Largest genealogy database — US records dating to 16th century plus 80+ countries international records
- DNA ethnicity estimates and shared DNA matching (20M+ DNA customers)
- Hints system — AI-powered suggestions of records that match your tree members
~$109M/mo company-wide (verified 2023 annual filing)
App only (Sensor Tower estimate): ~$2M/mo iOS US alone
- Billing abuse widely documented — $25 cancellation fees not disclosed at signup, unauthorized renewals at higher rates (ConsumerAffairs, 500+ complaints)
- Formerly free DNA features (shared matches) now paywalled as "AncestryDNA Plus" — users furious
- Purely genealogy — no health pattern identification, no medical history focus
- App UI rated "nearly impossible to navigate" by users; very slow on older devices
DNA upload required to use platform. Subscription: $9.99/month or $119/year (verified, selfdecode.com 2026). Full platform access from $319. Add-ons: Pharmacogenomics Report $99, Ancestry DNA report $79, importing raw DNA data $99. Raised $8M (2025, Wefunder). ARR: $2.5M (Wefunder disclosure). Est. ~$208K/mo.
- AI-powered health recommendations based on uploaded raw DNA (from 23andMe / AncestryDNA)
- 1,500+ trait and health reports from genetic data — supplements, lifestyle, medication compatibility
- Pharmacogenomics: how your genes affect response to 50+ medications ($99 add-on)
- DNA required as hard prerequisite — immediate barrier for privacy-conscious users post-23andMe
- Misleading renewal email subjects cause subscription charges users missed (Trustpilot, multiple reports)
- App has not updated in 2+ years; persistent login bug (logged out every session)
- Complex, overwhelming UI — information density too high for general consumers
- Individual DNA only — no family history mode, no multi-generational risk view
Across all five competitors, four failure modes appear consistently: (1) subscription billing abuse or complexity that generates user fury; (2) DNA requirements that block privacy-conscious users; (3) genealogy focus with zero medical/hereditary health context; (4) cloud-dependent architectures that expose health data. LineageMD avoids all four by design.
Positioning Recommendations
Based on competitor weaknesses and the verified gap in the market, the following positioning recommendations are ranked by impact.
SelfDecode requires DNA. MyHeritage and Ancestry aggressively push DNA kits. In the wake of 23andMe's 15M+ user data transfer (July 2025), privacy anxiety around genetic data is at an all-time high. "Your health history stays on your iPhone — no DNA swab, no data broker" is a message that resonates immediately in paid search, App Store screenshots, and Reddit communities where ex-23andMe users are actively looking for alternatives.
Every significant competitor runs subscriptions that users hate. Ancestry at $45/month-plus. MyHeritage at $199/year with surprise renewals. The one-time $7.99 unlock is an emotional relief in this category. It should appear in the App Store subtitle, the first screenshot, and every marketing message. Framing: "Not a subscription. Not a DNA service. Just $7.99 — yours forever."
FamGenix markets to clinicians. Ancestry markets to history enthusiasts. No competitor is marketing to the exact moment when a person sits in a doctor's office and gets asked "any family history of heart disease?" — and has no answer. App Store screenshots should depict this scenario. First screenshot: "Your doctor just asked about your family history. Do you know the answer?" This is the pain point that makes users download immediately.
SelfDecode does AI health analysis — but it runs in the cloud and requires you to upload your DNA. LineageMD's Foundation Models AI runs entirely on your iPhone, with zero data ever leaving the device. This is the privacy-first positioning that resonates with the post-23andMe audience. On-device AI isn't just a technical choice — it's a trust signal. "AI that never sees a server."
FamGenix is the closest direct competitor on purpose — but its UI is designed for genetic counselors, not families. Multiple real reviews cite: "feels like a medical form," "intimidating," "missing common conditions." LineageMD's differentiator here is aesthetic and UX: the family tree builder should feel like building a photo album, not filling out a hospital intake form. Use warm illustrations, guided onboarding, and conversational AI prompts — not clinical dropdowns.
Ancestry and MyHeritage spend on TV. SelfDecode relies on content marketing. No competitor is actively seeding in the communities where LineageMD's exact target user lives: r/medicine, r/23andme, r/BRCA (hereditary cancer community), r/caregivers. A single authentic post ("I built an app that makes family health history doctor-ready — no DNA, no subscription, $7.99") in these communities can drive hundreds of downloads. This is a zero-cost acquisition channel that all competitors are ignoring.
Opportunity Gap Summary
The following gaps were confirmed through feature matrix analysis, competitor review mining, and App Store search verification. Each represents a validated unmet need — not an assumption.
Confirmed absent from all 5 competitors for consumer users. FamGenix has a clinical pedigree share — but it's designed for genetic counselors, not patients sharing with a GP. Not one consumer iOS app produces a formatted, printable family history PDF. This is the #1 feature doctors actually request of patients.
SelfDecode does AI health analysis but requires cloud upload of DNA. No competitor uses on-device AI to identify hereditary risk patterns from manually entered family history — the exact data doctors use. Foundation Models enables this without any server, making it uniquely private and uniquely possible in 2026.
Every subscription competitor has generated significant user backlash over billing. Ancestry, MyHeritage, and SelfDecode all have hundreds to thousands of billing complaints on ConsumerAffairs, Trustpilot, and PissedConsumer. A $7.99 one-time purchase in this environment is not just affordable — it's politically differentiated in a trust-broken market.
15M+ 23andMe users had their DNA transferred to TTAM in July 2025. This created an unprecedented demand for health tracking tools that explicitly do NOT require genetic data. No competitor has repositioned to capture this audience. The "no DNA required" message has a ready-made audience of millions of privacy-motivated health consumers with no good options.
FamGenix is the closest competitor on concept but is designed for hospitals. Users describe it as "a medical form, not an app." Ancestry and MyHeritage have consumer-grade UX — but for genealogy, not health. The intersection of beautiful consumer UI + family health history (not genealogy) is completely unoccupied.
SelfDecode provides genetic health risk analysis — but requires a DNA kit. For the majority of users who either can't afford, don't want, or distrust DNA testing, there is no tool that synthesizes multi-generational health history into actionable risk patterns. This is a large underserved audience: privacy-conscious adults with family history of serious disease who want insights without giving up their genetics.
Every competitor forces a choice between privacy, price, or clinical utility. LineageMD delivers all three simultaneously. The market gap is real, verified, and currently unoccupied. The window to establish category ownership is open in 2026 — particularly given the 23andMe trust collapse creating active demand for privacy-first health alternatives.
Recommended Immediate Actions
| Action | Priority | Rationale |
|---|---|---|
Register com.lineagemd.app bundle ID in App Store Connect |
P0 — Today | Locks the name before any competitor can claim it. LineageMD confirmed clear on iOS and Android. |
Register lineagemd.com and lineagemd.app |
P0 — Today | Both confirmed available at $11.25/yr and $14.99/yr respectively (Vercel domain tool, April 2026). |
| Begin S1 build — SwiftData schema + tree UI | P1 — This week | No competitor holds a moat. Speed to market matters when the space is this open. |
| Join r/23andme, r/BRCA, r/medicine subreddits as a user | P2 — Pre-launch | Build authentic community presence before launch for zero-cost launch seeding. |
| Draft "23andMe alternative" press angle | P2 — Pre-launch | The TTAM data transfer story is still active. Health tech journalists are primed to cover alternatives. |